Company Filing History:
Years Active: 2001
Title: Johann Mörsdorf: Innovator in Thermally Stable Trimetrexate
Introduction
Johann Mörsdorf is a distinguished inventor based in Langenzenn, Germany. With a focus on pharmaceutical innovations, he has made significant contributions to the field, particularly in the development of thermally stable forms of trimetrexate. His groundbreaking work has implications for the stability and efficacy of pharmaceutical compounds.
Latest Patents
Johann Mörsdorf holds a patent titled "Thermally Stable Trimetrexates and Processes for Producing the Same." This patent reveals his innovative approach to creating crystalline forms of 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, commonly known as trimetrexate. The invention details a crystalline monohydrate that exhibits improved stability compared to its anhydrous counterpart, which is crucial for pharmaceutical applications. The patent also introduces a novel Schiff base compound, enhancing the potential for further development of stable trimetrexate free base compounds.
Career Highlights
Johann Mörsdorf is associated with MedImmune Oncology, Inc., a notable company engaged in innovative pharmaceutical research. His work at MedImmune has focused on advancing drug formulations, particularly in oncology, where stability of compounds is vital for therapeutic effectiveness. His singular patent reflects his capacity for innovation within this demanding field.
Collaborations
Mörsdorf has collaborated with esteemed professionals, including Martin Stogniew and Ingomar Grafe, contributing to a team that underscores the importance of collaboration in advancing scientific research. Their collective efforts have enhanced the scope and impact of their research projects.
Conclusion
In conclusion, Johann Mörsdorf stands out as an impactful inventor in the pharmaceutical sector, specifically through his patented work on thermally stable trimetrexate. His contributions not only showcase his innovative spirit but also highlight the importance of stability in drug formulations. As he continues to push the boundaries of pharmaceutical research, his work will undoubtedly inspire future innovations in the field.